logo
logo

Latest Financial Updates

Read latest financial news update from our blog

Metagenomi shares target cut by +40% on Pfizer gene therapy results By Investing.com
Metagenomi shares target cut by +40% on Pfizer gene therapy results By Investing.com

On Wednesday, H.C. Wainwright adjusted its outlook on Metagenomi Inc (NASDAQ:MGX), lowerin...

Admin | Finance | 12 weeks ago

read more
Abbott Laboratories: An Exploration into Its Intrinsic Value
Abbott Laboratories: An Exploration into Its Intrinsic Value

In this article, we will take a look into Abbott Laboratories's (ABT, Financial) DCF analy...

Admin | Finance | 12 weeks ago

read more
Abbott Laboratories: An Exploration into Its Intrinsic Value
Abbott Laboratories: An Exploration into Its Intrinsic Value

In this article, we will take a look into Abbott Laboratories's (ABT, Financial) DCF analy...

Admin | Finance | 12 weeks ago

read more
Measuring upward mobility in developing countries
Measuring upward mobility in developing countries

Read "Upward Mobility in Developing Countries" by Garance Genicot, Debraj Ray & Carolina C...

Admin | Finance | 12 weeks ago

read more
Target stock is soaring because price cuts are paying off big
Target stock is soaring because price cuts are paying off big

In This Story TGT Target’s price cuts are finally paying off. Sales at the retail gian...

Admin | Finance | 12 weeks ago

read more
Target stock is soaring because price cuts are paying off big
Target stock is soaring because price cuts are paying off big

In This Story TGT Target’s price cuts are finally paying off. Sales at the retail gian...

Admin | Finance | 12 weeks ago

read more
Dycom Industries Inc. Q2 2025 Earnings: EPS of $2.32, Revenue at $1.203 Billion, Surpassing Estimates
Dycom Industries Inc. Q2 2025 Earnings: EPS of $2.32, Revenue at $1.203 Billion, Surpassing Estimates

On August 21, 2024, Dycom Industries Inc (DY, Financial) released its 8-K filing for the f...

Admin | Finance | 12 weeks ago

read more
Syngene - Reality Check On Recovery? Stay Positive For Now: Yes Securities
Syngene - Reality Check On Recovery? Stay Positive For Now: Yes Securities

Syngene - Reality Check On Recovery? Stay Positive For Now: Yes Securities Syngene had ma...

Admin | Finance | 12 weeks ago

read more

Join Our Newsletter

join our newsletter to receive update from us